<DOC>
	<DOCNO>NCT00206206</DOCNO>
	<brief_summary>In response evidence support “ tight ” glucose control ( 70 – 110 ) critical care set , MMH ICU develop protocol utilize regular intravenous insulin . This protocol initiated 2002 . Monitoring data collect reveal effective glycemic control protocol use . However , limited utilization lead overall ineffective glycemic control ICU . The poor utilization largely due general reluctance physician start patient intravenous insulin infusion . As contribute poor compliance “ open ” nature ICU . The MMH ICU “ open ” ICU , mean many physician across multiple subspecialties admit unit . Approaches control hyperglycemia vary greatly , depend largely upon treat physician . In attempt improve overall glycemic control “ open ” ICU , Subcutaneaous Insulin Aspart Hyperglycemia Protocol ( SIAP ) develop incorporate subcutaneous insulin aspart regimen trigger use regular insulin infusion protocol SIAP adequately control patient ’ blood glucose . This study aim evaluate 1 ) effect SIAP overall glycemic control ICU , 2 ) effectiveness SIAP control blood glucose compare past practice use regular insulin , 3 ) effect SIAP patient complication outcomes MMH ICU .</brief_summary>
	<brief_title>Evaluation ICU Hyperglycemia Protocol Using Insulin Aspart</brief_title>
	<detailed_description />
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<criteria>Valid physician order protocol . No valid phycician order protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
</DOC>